Abeona Therapeutics Inc.
ABEO
$5.32
-$0.08-1.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.82M | 400.00K | 400.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.82M | 400.00K | 400.00K | -- | -- |
| Cost of Revenue | 30.24M | 29.68M | 33.92M | 37.09M | 34.36M |
| Gross Profit | -24.42M | -29.28M | -33.52M | -37.09M | -34.36M |
| SG&A Expenses | 65.03M | 53.93M | 41.02M | 32.51M | 29.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.27M | 83.61M | 74.94M | 69.61M | 64.21M |
| Operating Income | -89.45M | -83.21M | -74.54M | -69.61M | -64.21M |
| Income Before Tax | 71.28M | 82.67M | 72.75M | -44.19M | -63.73M |
| Income Tax Expenses | 100.00K | 315.00K | 15.51M | -- | -- |
| Earnings from Continuing Operations | 71.18 | 82.35 | 57.24 | -44.19 | -63.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.18M | 82.35M | 57.24M | -44.19M | -63.73M |
| EBIT | -89.45M | -83.21M | -74.54M | -69.61M | -64.21M |
| EBITDA | -86.90M | -80.98M | -72.43M | -67.56M | -62.21M |
| EPS Basic | 1.36 | 1.54 | 1.01 | -0.88 | -1.79 |
| Normalized Basic EPS | -0.95 | -0.84 | -1.00 | -0.55 | -1.12 |
| EPS Diluted | 0.99 | 1.17 | 0.64 | -1.33 | -2.24 |
| Normalized Diluted EPS | -0.88 | -0.77 | -0.93 | -0.57 | -1.14 |
| Average Basic Shares Outstanding | 211.76M | 205.23M | 199.07M | 186.55M | 164.09M |
| Average Diluted Shares Outstanding | 225.88M | 219.34M | 213.18M | 197.77M | 175.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |